149 related articles for article (PubMed ID: 2126953)
1. Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells.
Kaneko F; Suzuki M; Takiguchi Y; Itoh N; Minagawa T
J Dermatol Sci; 1990 Nov; 1(6):425-34. PubMed ID: 2126953
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
[TBL] [Abstract][Full Text] [Related]
3. The effect of IFN-gamma on healthy and psoriatic keratinocytes in a skin equivalent model is influenced by the source of the keratinocytes and by their interactions with fibroblasts.
Fransson J; Shen Q; Scheynius A; Hammar H
Arch Dermatol Res; 1996 Dec; 289(1):14-20. PubMed ID: 9017130
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis.
Huang BB; Bonish BK; Chaturvedi V; Qin JZ; Nickoloff BJ
J Invest Dermatol; 2001 Feb; 116(2):305-12. PubMed ID: 11180008
[TBL] [Abstract][Full Text] [Related]
5. Proliferation and interferon-gamma receptor expression in psoriatic and healthy keratinocytes are influenced by interactions between keratinocytes and fibroblasts in a skin equivalent model.
Fransson J; Emilson A; Scheynius A; Hammar H
Arch Dermatol Res; 1995; 287(6):517-23. PubMed ID: 7487135
[TBL] [Abstract][Full Text] [Related]
6. The cell-components and cytokines in the subcorneal microabscess of psoriasis.
Kaneko F; Itoh N; Yoshida H; Suzuki M; Ono I
Fukushima J Med Sci; 1991 Dec; 37(2):103-12. PubMed ID: 1823882
[TBL] [Abstract][Full Text] [Related]
7. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.
de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK
Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323
[TBL] [Abstract][Full Text] [Related]
8. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.
Griffiths CE; Voorhees JJ; Nickoloff BJ
J Am Acad Dermatol; 1989 Apr; 20(4):617-29. PubMed ID: 2497153
[TBL] [Abstract][Full Text] [Related]
9. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions.
Nickoloff BJ; Mitra RS; Elder JT; Fisher GJ; Voorhees JJ
Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168
[TBL] [Abstract][Full Text] [Related]
10. In situ localization of interferons in psoriatic lesions.
Livden JK; Nilsen R; Bjerke JR; Matre R
Arch Dermatol Res; 1989; 281(6):392-7. PubMed ID: 2480752
[TBL] [Abstract][Full Text] [Related]
11. UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions.
Baadsgaard O; Tong P; Elder JT; Hansen ER; Ho V; Hammerberg C; Lange-Vejlsgaard G; Fox DA; Fisher G; Chan LS
J Invest Dermatol; 1990 Sep; 95(3):275-82. PubMed ID: 1974570
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis.
Onuma S
J Dermatol; 1994 Apr; 21(4):223-32. PubMed ID: 7914525
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.
Bonish B; Jullien D; Dutronc Y; Huang BB; Modlin R; Spada FM; Porcelli SA; Nickoloff BJ
J Immunol; 2000 Oct; 165(7):4076-85. PubMed ID: 11034419
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of CD208 (DC-LAMP) in epidermal keratinocytes of psoriatic lesions.
Higaki M; Higaki Y; Kawashima M
J Dermatol; 2009 Mar; 36(3):144-9. PubMed ID: 19335688
[TBL] [Abstract][Full Text] [Related]
16. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets.
Szabo SK; Hammerberg C; Yoshida Y; Bata-Csorgo Z; Cooper KD
J Invest Dermatol; 1998 Dec; 111(6):1072-8. PubMed ID: 9856819
[TBL] [Abstract][Full Text] [Related]
17. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.
Teunissen MB; Koomen CW; de Waal Malefyt R; Wierenga EA; Bos JD
J Invest Dermatol; 1998 Oct; 111(4):645-9. PubMed ID: 9764847
[TBL] [Abstract][Full Text] [Related]
19. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes.
Paukkonen K; Naukkarinen A; Horsmanheimo M
Arch Dermatol Res; 1995; 287(2):165-70. PubMed ID: 7763088
[TBL] [Abstract][Full Text] [Related]
20. An altered response by psoriatic keratinocytes to gamma interferon.
Baker BS; Powles AV; Valdimarsson H; Fry L
Scand J Immunol; 1988 Dec; 28(6):735-40. PubMed ID: 3148190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
